
03/13/2025
Great news for patients experiencing recurrent C-diff infections
After a recent $106.5m fundraise, the designation marks another milestone for the company set to start a Phase III study later this year.
Clinical Research site
3030 Lawrence Avenue E
Toronto, ON
M1P2T7
Be the first to know and let us send you an email when Viable Clinical Research Scarborough Ontario posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Viable Clinical Research Scarborough Ontario: